Carl Olsson, MD

Articles by Carl Olsson, MD

Dr. Olsson on Differences Between LHRH Agonists and Antagonists in Prostate Cancer

January 19th 2017

Carl Olsson, MD, Integrated Medical Professionals, compares the efficacy of LHRH agonists with antagonists, which are commonly used to treat patients with prostate cancer.

Latest Updated Articles

Dr. Olsson on Differences Between LHRH Agonists and Antagonists in Prostate Cancer
January 19th 2017

Carl Olsson, MD

Articles by Carl Olsson, MD

Dr. Olsson on Differences Between LHRH Agonists and Antagonists in Prostate Cancer

Latest Updated Articles

Trending on OncLive

FDA Grants Fast Track Designation to LYT-200 in R/R High-Risk MDS

Japan Approves Subcutaneous Pembrolizumab for All Approved Pembrolizumab Indications

NAPISTAR-1-01 Data Support Rapid TUB-040 Development in Biomarker-Unrestricted Ovarian Cancer

Integrating Bispecific Antibodies Into Frontline Therapy for Newly Diagnosed Multiple Myeloma

Real-World Data Reinforce Liso-Cel Efficacy in R/R MCL